L2 Asset Management’s PetMed Express PETS Stock Holding History

L2 Asset Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,501	Closed	-$543	–	223
2023 Q3	$543	Buy	+10,501	New	+$130K	﹤0.01%	214

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

L2 Asset Management's PETS Position: Q4 2023 in Review

L2 Asset Management sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 10,501 shares — an estimated $543 sold.

L2 Asset Management first reported a position in PETS in Q3 2023 and held it in 1 quarter. The position peaked at $543 in Q3 2023. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

L2 Asset Management reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
L2 Asset Management sold 10,501 PetMed Express shares in Q4 2023, an estimated $543.
L2 Asset Management first reported a position in PetMed Express in Q3 2023 and held it in 1 quarter.
L2 Asset Management's PetMed Express position peaked at $543 in Q3 2023.
130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on L2 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.